sodium chlorite
Small moleculeexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2010 (NCT01091142)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- np001
- np001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06671236 | Phase 1 | Nov 30, 2024 | Novabio Therapeutics, Zhengzhou University |
| NCT03179501 | Phase 1 | Aug 1, 2017 | Neuraltus Pharmaceuticals, Inc., University of Hawaii |
| NCT02794857 | Phase 2 | Aug 1, 2016 | Neuraltus Pharmaceuticals, Inc., University of California, San Francisco |
| NCT01281631 | Phase 2 | Feb 1, 2011 | Neuraltus Pharmaceuticals, Inc., University of California, San Francisco |
| NCT01091142 | Phase 1 | Jul 1, 2010 | Neuraltus Pharmaceuticals, Inc., University of California, San Francisco |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Neuraltus Pharmaceuticals, Inc. | For profit | 4 | 3 | 2 | 2010 |
| University of California, San Francisco | Academic/Hospital | 3 | 0 | 2 | 2010 |
| Novabio Therapeutics | For profit | 1 | 1 | 1 | 2024 |
| University of Hawaii | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Zhengzhou University | Academic/Hospital | 1 | 0 | 1 | 2024 |
5 organizations
Page 1 / 1